BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

CUSIP: 07782B104

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Ordinary Shares, par value US$0.0001 per share
Shares outstanding
37,379,062
Total 13F shares
850,185
Share change
-7,144
Total reported value
$25,389,513
Price per share
$29.90
Number of holders
8
Value change
-$211,069
Number of buys
4
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q1 2023

As of 31 Mar 2023, BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 850,185 shares. The largest 8 holders included Atria Wealth Solutions, Inc., ALPS ADVISORS INC, STATE STREET CORP, Qube Research & Technologies Ltd, BlackRock Inc., MORGAN STANLEY, UBS Group AG, and Royal Bank of Canada. This page lists 8 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.